These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2631519)

  • 1. Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks.
    Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vzquez A; Dominguez R; Fraiman H; Vila J; Benjamin V; Matera V
    Acta Neurol Scand Suppl; 1989; 127():31-5. PubMed ID: 2631519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
    Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
    Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
    Herskovits E; Vazquez A; Famulari A; Smud R; Tamaroff L; Fraiman H; Gonzalez AM; Vila J; Matera V
    Lancet; 1981 May; 1(8227):966-8. PubMed ID: 6112386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
    Lucas MA
    Angiology; 1984 Jul; 35(7):443-50. PubMed ID: 6465619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.
    Dengler R; Diener HC; Schwartz A; Grond M; Schumacher H; Machnig T; Eschenfelder CC; Leonard J; Weissenborn K; Kastrup A; Haberl R;
    Lancet Neurol; 2010 Feb; 9(2):159-66. PubMed ID: 20060783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.
    Halkes PH; Gray LJ; Bath PM; Diener HC; Guiraud-Chaumeil B; Yatsu FM; Algra A
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1218-23. PubMed ID: 18535024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
    Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
    Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
    Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention with clopidogrel after TIA or stroke].
    Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
    Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of aspirin and dipyridamole in the treatment of acute ischaemic stroke/transient ischaemic attack: an audit-based discussion.
    Khalil S; Mohanaruban K; Haq S
    Clin Med (Lond); 2009 Apr; 9(2):196-7. PubMed ID: 19437733
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentoxifylline for transient ischaemic attacks.
    Warlow C; Peto R
    Lancet; 1981 May; 1(8229):1103-4. PubMed ID: 6112470
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
    Chaturvedi S
    Clin Ther; 2008 Jul; 30(7):1196-205. PubMed ID: 18691981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.